Upgrade to SI Premium - Free Trial

Biomea Fusion (BMEA) Reiterated at Market Outperform by Citizens - Time to 'Revisit This Story'

September 30, 2026 4:13 AM
Citizens analyst Jonathan Wolleben reiterated a Market Outperform rating and $7.00 price target on Biomea Fusion Inc. (NASDAQ: BMEA).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments